|
PARP4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8673899999988E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.174400E-04 |
| Normal-vs-Stage2 |
5.487800E-02 |
| Normal-vs-Stage3 |
2.19440000004401E-06 |
| Normal-vs-Stage4 |
4.542000E-03 |
| Stage1-vs-Stage2 |
4.361800E-01 |
| Stage1-vs-Stage3 |
7.489900E-02 |
| Stage1-vs-Stage4 |
8.773000E-01 |
| Stage2-vs-Stage3 |
8.930300E-02 |
| Stage2-vs-Stage4 |
4.653200E-01 |
| Stage3-vs-Stage4 |
3.360400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.7828000000073E-05 |
| Normal-vs-AfricanAmerican |
1.75403000000074E-05 |
| Normal-vs-Asian |
6.469600E-01 |
| Caucasian-vs-AfricanAmerican |
7.142100E-02 |
| Caucasian-vs-Asian |
4.410300E-02 |
| AfricanAmerican-vs-Asian |
5.202500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.634700E-04 |
| Normal-vs-Female |
1.79213000000011E-05 |
| Male-vs-Female |
9.270100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.997560E-03 |
| Normal-vs-Age(41-60Yrs) |
2.376600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.69959999998903E-06 |
| Normal-vs-Age(81-100Yrs) |
5.358000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.630970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.107800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.064400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.938000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.948400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.509450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.407210E-01 |
| Normal-vs-Grade 2 |
2.220600E-04 |
| Normal-vs-Grade 3 |
5.71429999999262E-05 |
| Normal-vs-Grade 4 |
4.161800E-04 |
| Grade 1-vs-Grade 2 |
8.192800E-01 |
| Grade 1-vs-Grade 3 |
7.032800E-01 |
| Grade 1-vs-Grade 4 |
4.832600E-01 |
| Grade 2-vs-Grade 3 |
6.995800E-01 |
| Grade 2-vs-Grade 4 |
2.543000E-01 |
| Grade 3-vs-Grade 4 |
3.615200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.842460E-03 |
| Normal-vs-ccB subtype |
6.421600E-04 |
| ccA subtype-vs-ccB subtype |
4.222800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.231600E-04 |
| Normal-vs-N1 |
4.374600E-01 |
| N0-vs-N1 |
3.462800E-01 |
|
|
